In this study, we demonstrate that DCLK1 down-regulation in HNSCC cells by siRNA-mediated knockdown or through pharmacologic inhibition in vitro resulted in reduced cancer cell proliferation, migration, and cell invasion. The gene discussed is DCLK1; the disease is cancer.